AZYRADA

Welcome to the Brand page for “AZYRADA”, which is offered here for Anti-inflammatory preparations; pharmaceutical preparations for the treatment of autoimmune diseases, rheumatoid arthritis, plaque psoriasis, crohn's disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis;.

Its status is currently believed to be active. Its class is unavailable. “AZYRADA” is believed to be currently owned by “Pfizer Inc.”